Prudential Financial Portfolio holdings
AUM
$77.4B
1-Year Return
21.48%
This Quarter Return
+12.74%
1 Year Return
+21.48%
3 Year Return
+96.22%
5 Year Return
+175.48%
10 Year Return
+394.71%
AUM
$66.2B
AUM Growth
+$2.36B
(+3.7%)
Cap. Flow
-$4.5B
Cap. Flow
% of AUM
-6.8%
Top 10 Holdings %
Top 10 Hldgs %
26.27%
Holding
2,763
New
170
Increased
1,022
Reduced
1,381
Closed
119
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.25B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$294M |
| 3 |
S&P Global
SPGI
|
+$128M |
| 4 |
iShares Russell 1000 Growth ETF
IWF
|
+$123M |
| 5 |
iShares Russell 1000 Value ETF
IWD
|
+$122M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$441M |
| 2 |
Apple
AAPL
|
+$425M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$341M |
| 4 |
Eli Lilly
LLY
|
+$255M |
| 5 |
Mastercard
MA
|
+$221M |
Sector Composition
| 1 | Technology | 23.69% |
| 2 | Financials | 10.78% |
| 3 | Healthcare | 10.73% |
| 4 | Consumer Discretionary | 9.54% |
| 5 | Industrials | 7.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Esperion Therapeutics
ESPR
$506M
| $99.4K | ﹤0.01% |
33,260
| – | – |
|
2502
MBIA
MBI
$386M
| $99.2K | ﹤0.01% |
+16,209
| New | +$99.2K |
|
2503
Magnite
MGNI
$3.61B
| $98K | ﹤0.01% |
10,492
+290
| +3% | +$2.71K |
|
2504
Ardelyx
ARDX
$1.59B
| $97.7K | ﹤0.01% |
15,750
+1,460
| +10% | +$9.05K |
|
2505
Kodiak Sciences
KOD
$517M
| $93.7K | ﹤0.01% |
30,808
| – | – |
|
2506
Brookdale Senior Living
BKD
$1.84B
| $90.4K | ﹤0.01% |
15,529
-9,620
| -38% | -$56K |
|
|
AIV
2507
Aimco
AIV
$1.1B
| $89.9K | ﹤0.01% |
11,478
-35,632
| -76% | -$279K |
|
2508
Rigel Pharmaceuticals
RIGL
$733M
| $89.7K | ﹤0.01% |
6,186
| – | – |
|
2509
NatWest
NWG
$56.8B
| $89.1K | ﹤0.01% |
15,830
+1,357
| +9% | +$7.64K |
|
2510
Shattuck Labs
STTK
$90.1M
| $87K | ﹤0.01% |
12,200
-5,600
| -31% | -$39.9K |
|
2511
BioCryst Pharmaceuticals
BCRX
$1.72B
| $86.6K | ﹤0.01% |
14,465
+460
| +3% | +$2.76K |
|
2512
Caribou Biosciences
CRBU
$169M
| $85.5K | ﹤0.01% |
14,924
+2,314
| +18% | +$13.3K |
|
2513
AvePoint
AVPT
$3.51B
| $84.7K | ﹤0.01% |
10,315
| – | – |
|
2514
B2Gold
BTG
$5.68B
| $84.2K | ﹤0.01% |
+26,499
| New | +$84.2K |
|
|
PSTX
2515
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $81.9K | ﹤0.01% |
24,380
| – | – |
|
2516
Coeur Mining
CDE
$9.36B
| $79.3K | ﹤0.01% |
24,336
+810
| +3% | +$2.64K |
|
2517
Geron
GERN
$874M
| $77.7K | ﹤0.01% |
36,817
+1,620
| +5% | +$3.42K |
|
2518
Crexendo
CXDO
$194M
| $76.6K | ﹤0.01% |
15,800
-4,200
| -21% | -$20.4K |
|
2519
Xeris Biopharma Holdings
XERS
$1.25B
| $74K | ﹤0.01% |
31,475
| – | – |
|
2520
Puma Biotechnology
PBYI
$230M
| $71K | ﹤0.01% |
16,400
| – | – |
|
2521
Compass
COMP
$5.02B
| $70.7K | ﹤0.01% |
18,815
| – | – |
|
2522
MannKind Corp
MNKD
$1.71B
| $70.7K | ﹤0.01% |
19,421
-26,030
| -57% | -$94.7K |
|
|
INFN
2523
DELISTED
Infinera Corporation Common Stock
INFN
| $70.2K | ﹤0.01% |
14,775
+540
| +4% | +$2.57K |
|
2524
Cerus
CERS
$249M
| $67K | ﹤0.01% |
31,007
+19,390
| +167% | +$41.9K |
|
2525
Neuronetics
STIM
$223M
| $65K | ﹤0.01% |
22,400
| – | – |
|